SCHEMBL29483333

SCHEMBL29483333

CCCC/C=C/OC(=O)c1ccccc1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.49
TDP1 Q9NUW8 3/20 0.47
TSHR P16473 5/20 0.47
NAAA Q02083 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
MAPK1 P28482 2/20 0.43
TP53 P04637 1/20 0.43
CYP3A4 P08684 1/20 0.43
ALDH1A1 P00352 3/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43
KDM4E B2RXH2 1/20 0.43
GAA P10253 1/20 0.43
BID P55957 3/20 0.42
BCL2L1 Q07817 3/20 0.42
MCL1 Q07820 3/20 0.42
BAK1 Q16611 3/20 0.42
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL404921 1.00 LMNA (0.49) LMNATDP1TSHRNAAAL3MBTL1
SCHEMBL3637873 1.00 LMNA (0.49) LMNATDP1TSHRNAAAL3MBTL1
SCHEMBL31110234 1.00 LMNA (0.49) LMNATDP1TSHRNAAAL3MBTL1
SCHEMBL29356105 1.00 LMNA (0.49) LMNATDP1TSHRNAAAL3MBTL1
SCHEMBL404922 1.00 LMNA (0.49) LMNATDP1TSHRNAAAL3MBTL1
SCHEMBL9941712 0.94 NAAA (0.49) LMNATDP1TSHRNAAAMAPK1
SCHEMBL9941713 0.94 NAAA (0.49) LMNATDP1TSHRNAAAMAPK1
SCHEMBL30668445 0.88 KDM4E (0.48) LMNATDP1TSHRNAAAL3MBTL1
SCHEMBL6307972 0.85 ALDH1A1 (0.50) LMNATDP1TSHRL3MBTL1MAPK1
SCHEMBL6307976 0.85 ALDH1A1 (0.50) LMNATDP1TSHRL3MBTL1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250283018-A1 TOILET RIM BLOCKS WITH SCENT CHANGE SYMRISE AG (DE) 2025-09-11 US claimed
US-12577495-B2 Fragrance mixtures containing 1-(4,4-dimethylcyclohexen-1-yl) ethanon SYMRISE AG (DE) 2026-03-17 US disclosed
EP-4045490-B1 NEW AROMATIC MONOTHIOKETALS AS FRAGRANCES SYMRISE AG (DE) 2025-12-03 EP disclosed
US-20250319006-A1 ETHYL 2-CYCLOOCTYLACETATE AS A FRAGRANCE SYMRISE AG (DE) 2025-10-16 US disclosed
US-20250283018-A1 TOILET RIM BLOCKS WITH SCENT CHANGE SYMRISE AG (DE) 2025-09-11 US disclosed
US-20250170074-A1 PRECURSORS FOR THE CONTROLLED RELEASE OF A,B-UNSATURATED ALDEHYDES OR KETONES AND OTHER HIGH IMPACT FRAGRANCE SUBSTANCES SYMRISE AG (DE) 2025-05-29 US disclosed
US-20250144589-A1 Method for Producing Microcapsules SYMRISE AG (DE) 2025-05-08 US disclosed
EP-4373805-B1 PRECURSORS FOR THE CONTROLLED RELEASE OF ALPHA, BETA-UNSATURATED ALDEHYDES OR KETONES AND OTHER HIGH IMPACT FRAGRANCE SUBSTANCES SYMRISE AG (DE) 2025-04-09 EP disclosed
EP-4472763-A1 METHOD FOR PRODUCING MICROCAPSULES Symrise AG (DE) 2024-12-11 EP disclosed
EP-3924102-B1 METHOD FOR PRODUCING MICROCAPSULES SYMRISE AG (DE) 2024-12-11 EP disclosed
EP-4282853-A1 PROCESS FOR THE PREPARATION OF MESACONIC ACID ESTERS Symrise AG (DE) 2023-11-29 EP disclosed
WO-2023148253-A1 METHOD FOR PRODUCING MICROCAPSULES SYMRISE AG (DE) 2023-08-10 WO disclosed
WO-2023147855-A2 PROCESS FOR PRODUCING MICROCAPSULES SYMRISE AG (DE) 2023-08-10 WO disclosed
WO-2023147889-A1 PROCESS FOR PRODUCING MICROCAPSULES SYMRISE AG (DE) 2023-08-10 WO disclosed
US-20230227752-A1 FRAGRANCE MIXTURES CONTAINING 1-(4,4-DIMETHYLCYCLOHEXEN-1-YL) ETHANON SYMRISE AG (DE) 2023-07-20 US disclosed
EP-4069412-A1 ENCAPSULATED ODORANTS BASED ON NATURAL AMINO ACIDS Symrise AG (DE) 2022-10-12 EP disclosed
EP-3969164-A1 METHOD FOR PRODUCING MICROCAPSULES Symrise AG (DE) 2022-03-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250319006-A1 ETHYL 2-CYCLOOCTYLACETATE AS A FRAGRANCE ACMSD, FAAH2, FAAH LMNA 4192/4885TDP1 4073/4885TSHR 4779/4885
US-20250170074-A1 PRECURSORS FOR THE CONTROLLED RELEASE OF A,B-UNSATURATED ALDEHYDES OR KETONES AND OTHER HIGH IMPACT FRAGRANCE SUBSTANCES FAAH2, TRPA1, FAAH LMNA 2629/4885TDP1 4121/4885TSHR 4023/4885
US-12577495-B2 Fragrance mixtures containing 1-(4,4-dimethylcyclohexen-1-yl) ethanon ALG3, FAAH, FAAH2 LMNA 3213/4885TDP1 3880/4885TSHR 4433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.